4.7 Article

Ambient Temperature Stable, Scalable COVID-19 Polymer Particle Vaccines Induce Protective Immunity

Related references

Note: Only part of the references are listed.
Article Engineering, Biomedical

Polymeric nanoparticle vaccines to combat emerging and pandemic threats

David Wibowo et al.

Summary: Subunit vaccines have advantages in safety and scale-up manufacture compared to live attenuated vaccines, but often sacrifice efficacy. Polymeric nanoparticles have been developed to enhance vaccine potency by incorporating multiple immunological cues to mimic pathogens. Studies show that modulation of the physicochemical properties of nanoparticles can improve vaccine delivery and immune responses.

BIOMATERIALS (2021)

Article Multidisciplinary Sciences

A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses

Tiong Kit Tan et al.

Summary: This study introduces a potential vaccine candidate against SARS-CoV-2, utilizing a synthetic virus-like particle platform to present the receptor-binding domain of the virus spike protein. The vaccine induces strong neutralizing antibody responses in mice and pigs, demonstrating thermostability and the potential for global distribution.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19

Adam K. Wheatley et al.

Summary: The durability of infection-induced SARS-CoV-2 immunity has major implications for reinfection and vaccine development. Antibody, B cell, and T cell responses decline over the first 4 months post-infection, while S-specific IgG(+) memory B cells consistently accumulate. The study suggests that natural infection may only provide transient protection at a population level, highlighting the need for more immunogenic and durable vaccines.

NATURE COMMUNICATIONS (2021)

Review Immunology

SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates

Nikolaos C. Kyriakidis et al.

Summary: The new SARS-CoV-2 virus is rapidly spreading worldwide, causing the COVID-19 pandemic with more than 1.866 million deaths. Over 64 vaccine candidates are being developed globally, aiming to induce antibodies to prevent viral entry. Thirteen vaccine candidates are currently in Phase 3 clinical trials, showing promising progress towards approval for large-scale immunizations.

NPJ VACCINES (2021)

Article Medicine, General & Internal

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

Nina H. Schultz et al.

Summary: This study reports five cases of venous thrombosis and thrombocytopenia occurring 7 to 10 days after receiving the ChAdOx1 nCoV-19 vaccine, suggesting a rare vaccine-induced immune thrombotic thrombocytopenia. The condition, which can lead to catastrophic outcomes such as cerebral venous sinus thrombosis, may be treated with intravenous immune globulin.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Editorial Material Medicine, General & Internal

SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia

Douglas B. Cines et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals

Shota Yoshida et al.

Summary: This study aimed to understand adaptive immunity to SARS-CoV-2 by analyzing B cell epitopes and neutralizing activity in COVID-19 patients. Most patients showed neutralizing activity against SARS-CoV-2, with antibodies targeting the S protein or RBD, and a correlation between neutralizing antibody titer and IgG antibody titer. Analysis of patient serum revealed potential targets for vaccine development against SARS-CoV-2.

SCIENTIFIC REPORTS (2021)

Article Immunology

Nanovaccine: an emerging strategy

Amrita Das et al.

Summary: Nanovaccines, as efficient vaccine delivery systems, show great potential in improving tissue targeting, antigen presentation, and targeted delivery, providing promising strategies to combat infectious diseases and cancer.

EXPERT REVIEW OF VACCINES (2021)

Article Chemistry, Multidisciplinary

Particulate Mycobacterial Vaccines Induce Protective Immunity against Tuberculosis in Mice

Shuxiong Chen et al.

Summary: Current tuberculosis vaccines do not consistently protect against the disease, prompting the need for new and improved vaccines. Research has shown that mycobacterial antigen fusions assembled into particulate vaccines can induce long-lasting antigen-specific T cell responses and protective immunity in mice challenged with virulent Mycobacterium tuberculosis. This study demonstrated that polyester nanoparticles displaying the mycobacterial antigen fusion H4 can offer a level of protection in the lungs comparable to the currently approved TB vaccine, making it a promising subunit vaccine candidate for cost-effective manufacturing and efficient protection against TB.

NANOMATERIALS (2021)

Review Microbiology

Bacterial biopolymers: from pathogenesis to advanced materials

M. Fata Moradali et al.

NATURE REVIEWS MICROBIOLOGY (2020)

Article Biotechnology & Applied Microbiology

Covalent Functionalization of Bioengineered Polyhydroxyalkanoate Spheres Directed by Specific Protein-Protein Interactions

Jin Xiang Wong et al.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)

Editorial Material Medicine, Research & Experimental

SARS-CoV-2: a storm is raging

Savannah F. Pedersen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Multidisciplinary Sciences

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

Shutoku Matsuyama et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao et al.

SCIENCE (2020)

Article Microbiology

COVID-19: an Immunopathological View

Kamran Kadkhoda

MSPHERE (2020)

Article Multidisciplinary Sciences

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Bin Ju et al.

NATURE (2020)

Article Multidisciplinary Sciences

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

Sin Fun Sia et al.

NATURE (2020)

Article Multidisciplinary Sciences

A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity

Jingyun Yang et al.

NATURE (2020)

Letter Biotechnology & Applied Microbiology

Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures

Nikolai Eroshenko et al.

NATURE BIOTECHNOLOGY (2020)

Review Multidisciplinary Sciences

SARS-CoV-2 vaccines in development

Florian Krammer

NATURE (2020)

Article Biochemistry & Molecular Biology

Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters

Lisa H. Tostanoski et al.

NATURE MEDICINE (2020)

Article Multidisciplinary Sciences

Direct visualization of translational GTPase factor pool formed around the archaeal ribosomal P-stalk by high-speed AFM

Hirotatsu Imai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

A single dose of recombinant VSV-G-spike vaccine provides protection against SARS-CoV-2 challenge

Yfat Yahalom-Ronen et al.

NATURE COMMUNICATIONS (2020)

Article Nanoscience & Nanotechnology

Catalytically Active Bioseparation Resin Utilizing a Covalent Intermediate for Tagless Protein Purification

Ben Evert et al.

ACS APPLIED BIO MATERIALS (2020)

Review Immunology

Immunological considerations for COVID-19 vaccine strategies

Mangalakumari Jeyanathan et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

Innovative antigen carrier system for the development of tuberculosis vaccines

Shuxiong Chen et al.

FASEB JOURNAL (2019)

Review Biochemistry & Molecular Biology

Polyester as Antigen Carrier toward Particulate Vaccines

Majela Gonzalez-Miro et al.

BIOMACROMOLECULES (2019)

Article Biochemistry & Molecular Biology

Design of Modular Polyhydroxyalkanoate Scaffolds for Protein Immobilization by Directed Ligation

Jin Xiang Wong et al.

BIOMACROMOLECULES (2018)

Article Materials Science, Biomaterials

Design and Biological Assembly of Polyester Beads Displaying Pneumococcal Antigens as Particulate Vaccine

Majela Gonzalez-Miro et al.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2018)

Article Materials Science, Biomaterials

Design of Bacterial Inclusion Bodies as Antigen Carrier Systems

Shuxiong Chen et al.

ADVANCED BIOSYSTEMS (2018)

Review Biochemical Research Methods

Bioengineering towards self-assembly of particulate vaccines

Bernd H. A. Rehm

CURRENT OPINION IN BIOTECHNOLOGY (2017)

Review Immunology

Harnessing Nanoparticles for Immunomodulation and Vaccines

Ariane C. Gomes et al.

VACCINES (2017)

Article Biotechnology & Applied Microbiology

Surface display of highly-stable Desulfovibrio vulgaris carbonic anhydrase on polyester beads for CO2 capture

David O. Hooks et al.

BIOTECHNOLOGY LETTERS (2015)

Article Biotechnology & Applied Microbiology

Detoxifying Escherichia coli for endotoxin-free production of recombinant proteins

Uwe Mamat et al.

Microbial Cell Factories (2015)

Article Biotechnology & Applied Microbiology

Protein Production Using the Baculovirus-Insect Cell Expression System

A. Contreras-Gomez et al.

BIOTECHNOLOGY PROGRESS (2014)

Article Biochemistry & Molecular Biology

Structural Analysis and Optimization of the Covalent Association between SpyCatcher and a Peptide Tag

Long Li et al.

JOURNAL OF MOLECULAR BIOLOGY (2014)

Review Pharmacology & Pharmacy

Particulate vaccines: on the quest for optimal delivery and immune response

Marie-Luce De Temmerman et al.

DRUG DISCOVERY TODAY (2011)

Review Zoology

A fast track influenza virus vaccine produced in insect cells

Manon M. J. Cox et al.

JOURNAL OF INVERTEBRATE PATHOLOGY (2011)

Article Biotechnology & Applied Microbiology

One-Step Production of Immobilized α-Amylase in Recombinant Escherichia coli

Indira A. Rasiah et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2009)

Article Biotechnology & Applied Microbiology

In vivo enzyme immobilization by use of engineered polyhydroxyalkanoate synthase

V Peters et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2006)

Article Multidisciplinary Sciences

Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens

AL Ackerman et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)